AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitaglo M SR Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitaglo M SR Tablet

Sitaglo M SR Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially decreasing the risk of cardiovascular events. Sitaglo M SR may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal upset. Consistent, daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to your doctor's prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle significantly impacts glucose control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when co-administered with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't suitable for all patients. Prior to use, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require medical consultation before initiating treatment. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Sitaglo M SR Tablet

Managing type 2 diabetes

Major Benefits of Sitaglo M SR Tablet:

Follow your doctor's instructions or consult the product label for usage guidance. Take Sitaglo M SR Tablet with a meal.

Common Side effects of Sitaglo M SR Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo M SR Tablet:

Follow your doctor's instructions or refer to the product label for proper administration. Take Sitaglo M SR Tablet with a meal.

How Sitaglo M SR Tablet works:

Sitaglo M SR Tablet combines sitagliptin and metformin to improve blood sugar management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Sitaglo M SR Tablet.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitaglo M SR Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitaglo M SR Tablet while breastfeeding is likely unsafe. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitaglo M SR Tablets, potentially requiring dosage modification. Severe kidney disease contraindicates Sitaglo M SR Tablet use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should not take Sitaglo M SR Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaglo M SR Tablet :

Should you forget a Sitaglo M SR Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sitaglo M SR Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Sitaglo M SR Tablet

Sitagliptin and Metformin, combined as Sitaglo M SR Tablet, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose output and boosts insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, thereby promoting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitaglo M SR Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, recommended by some studies, involve annual supplemental vitamin B12 intake.
Sitaglo M SR Tablet may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Patients with a history of hypersensitivity to Sitaglo M SR Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M SR Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage directions provided on the label or packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Sitaglo M SR Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms may involve muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitagliptin and Metformin, combined as Sitaglo M SR Tablet, manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose output and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thereby promoting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo M SR Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo M SR Tablet ingredient or inactive substance should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M SR Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitaglo M SR Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent complication of metformin. Consequently, its use is contraindicated in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaglo M SR Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some studies involve annual supplemental vitamin B12 intake.
Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication appropriately. Prevent access by children, pets, and others.
Sitagliptin and Metformin, combined as Sitaglo M SR Tablet, treat type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin works by suppressing DPP4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitaglo M SR Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can also occur. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any constituent or inactive ingredient in Sitaglo M SR Tablet should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M SR Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitaglo M SR Tablet use carries a risk of lactic acidosis, a serious medical condition resulting from excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin, prompting its avoidance in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaglo M SR Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include supplemental vitamin B12 at least annually.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitaglo M SR Tablet
180
MRP 209
13% off